Phenotypic heterogeneity of sitosterolemia

Journal of Lipid Research

Volumn 45, Issue 12, 2004, Pages 2361-2367

  Wang, Jian ^a   Joy, Tisha ^a   Mymin, David ^b   Frohlich, Jiri ^c   Hegele, Robert A ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Bile acids; Genomic DNA; Intestinal absorption; Mutation; Sequence analysis; Sterols; Transporters

Indexed keywords

EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SITOSTEROL;

ABCG5 GENE; ABCG8 GENE; ABCG8 S107X GENE; ADULT; AGED; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BLOOD LEVEL; CLINICAL ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; EXON; FEMALE; GENE; GENE MUTATION; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; LIPOPROTEIN METABOLISM; MALE; METABOLIC DISORDER; PHENOTYPE; PRIORITY JOURNAL; SITOSTEROLEMIA; XANTHOMA;

EID: 10044251362     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M400310-JLR200     Document Type: Article

References (43)

1. Bhattacharyya, A. K., and W. E. Connor. 1974. β-Sitosterolemia and xanthomatosis - a newly described lipid storage disease in two sisters. J. Clin. Invest. 53: 1033-1043.
2. Beaty, T. H., P. O. Kwiterovich, Jr., M. J. Khoury, S. White, P. S. Bachorik, H. H. Smith, B. Teng, and A. Sniderman. 1986. Genetic analysis of plasma sitosterol, apolipoprotein B, and lipoproteins in a large Amish pedigree with sitosterolemia. Am. J. Hum. Genet. 38: 492-504.
3. Hidaka, H., H. Sugiura, T-A. Nakamura, H. Kojima, M. Fujita, N. Sugie, H. Okabe, Y. Nishio, H. Maegawa, A. Kashiwagi, and R. Kikkawa. 1997. β-Sitosterolemia with generalized eruptive xanthomatosis. Endocr. J. 44: 59-64.
4. Mietinnen, T. A. 1980. Phytosterolemia, xanthomatosis and premature coronary atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis. Eur. J. Clin. Invest. 10: 27-35.
5. Berger, G. M. B., W. M. Deppe, A. D. Marais, and M. Biggs. 1994. Phytosterolaemia in three unrelated South African families. Postgrad. Med. J. 70: 631-637.
6. Hidaka, H. T., T. Nakamura, T. Aoki, H. Kojima, Y. Nakajima, K. Kosugi, I. Hatanaka, M. Harada, M. Kobayashi, A. Tamara, T. Fugii, and Y. Shigeta. 1990. Increased plasma plant sterol levels in heterozygotes with sitosterolemia and xanthomatosis. J. Lipid Res. 31: 881-888.
7. Jansen, A. C. M., S. van Wissen, J. C. Defesche, and J. J. P. Kastelein. 2002. Phenotypic variability in familial hypercholesterolemia: an update. Curr. Opin. Lipidol. 13: 165-171.
8. Moghadasian, M. H., G. Salen, J. J. Frohlich, and C. H. Scudamore. 2002. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. Arch. Neurol. 59: 527-529.
9. Salen, G., P. O. Kwiterovich, Jr., S. Shefer, G. S. Tint, I. Horak, V. Shore, B. Dayal, and E. Horak. 1985. Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis. J. Lipid Res. 26: 203-209.
10. Salen, G., E. H. Ahrens, and S. M. Grundy. 1970. Metabolism of β-sitosterol in man. J. Clin. Invest. 49: 952-967.
11. Salen, G., S. Shefer, L. Nguyen, G. C. Ness, G. S. Tint, and V. Shore. 1992. Sitosterolemia. J. Lipid Res. 33: 945-955.
12. Lutjohann, D., I. Bjorkhem, U. F. Beil, and K. von Bergmann. 1995. Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: effect of sitostanol treatment. J. Lipid Res. 36: 1763-1773.
13. Shulman, R. S., A. K. Bhattacharyya, W. E. Connor, and D. S. Frederickson. 1976. β-Sitosterolemia and xanthomatosis. N. Engl. J. Med. 294: 472-483.
14. Salen, G., V. Shore, G. S. Tint, T. Forte, S. Shefer, I. Horak, E. Horak, B. Dayal, L. Nguyen, A. K. Batta, F. T. Lindgren, and P. O. Kwiterovich, Jr. 1989. Increased sitosterol absorption, decreased removal, and expanded body pools compensate for reduced cholesterol synthesis in sitosterolemia with xanthomatosis. J. Lipid Res. 30: 1319-1330.
15. Salen, G., G. S. Tint, S. Shefer, V. Shore, and L. Nguyen. 1992. Increased sitosterol absorption is offset by rapid elimination to prevent accumulation in heterozygotes with sitosterolemia. Arterioscler. Thromb. 12: 563-568.
16. Gregg, R. E., W. E. Connor, D. S. Lin, and H. B. Brewer, Jr. 1986. Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis. J. Clin. Invest. 77: 1864-1872.
17. Nguyen, L., G. Salen, S. Shefer, V. Shore, G. S. Tint, and G. Ness. 1990. Unexpected failure of bile acid malabsorption to stimulate cholesterol synthesis in sitosterolemia with xanthomatosis: comparison with lovastatin. Arteriosclerosis. 10: 289-297.
18. Nguyen, L. B., M. Cobb, S. Shefer, G. Salen, G. C. Ness, and G. S. Tint. 1991. Regulation of cholesterol biosynthesis in sitosterolemia: effects of lovastatin, cholestyramine, and dietary sterol restriction. J. Lipid Res. 32: 1941-1948.
19. Patel, S. B., A. Honda, and G. Salen. 1998. Sitosterolemia: exclusion of genes involved in reduced cholesterol biosynthesis. J. Lipid Res. 39: 1055-1061.
20. Patel, S. B., G. Salen, H. Hidaka, P. O. Kwiterovich, Jr., A. F. H. Stalenhoef, T. A. Mietinnen, S. M. Grundy, M-H. Lee, J. S. Rubenstein, M. H. Polymeropoulos, and M. J. Brownstein. 1998. Mapping a gene involved in regulating dietary cholesterol absorption - the sisterolemia locus is found at chromosome 2p21. J. Clin. Invest. 102: 1041-1044.
21. Lee, M-H., K. Lu, S. Hazard, H. Yu, S. Shulenin, H. Hidaka, H. Kojima, R. Allikmets, N. Sakuma, R. Pegoraro, A. K. Srivastava, G. Salen, M. Dean, and S. B. Patel. 2001. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat. Genet. 27: 79-83.
22. Berge, K. E., H. Tian, G. A. Graf, L. Yu, N. V. Grishin, J. Schultz, P. O. Kwiterovich, Jr., B. Shan, R. Barnes, and H. H. Hobbs. 2000. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 290: 1771-1775.
23. Lu, K., M-H. Lee, S. Hazard, A. Brooks-Wilson, H. Hidaka, H. Kojima, L. Ose, A. F. H. Stalenhoef, T. Mietinnen, I. Bjorkhem, E. Bruckert, A. Pandya, H. B. Brewer, Jr., G. Salen, M. Dean, A. Srivastava, and S. B. Patel. 2001. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am. J. Hum. Genet. 69: 278-290.
24. Hubacek, J. A., K. E. Berge, J. C. Cohen, and H. H. Hobbs. 2001. Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCGS) causing sitosterolemia. Hum. Mutat. 18: 359-360.
25. Heimerl, S., T. Langmann, C. Moehle, R. Mauerer, M. Dean, F-U. Beil, K. von Bergmann, and G. Schmitz. 2002. Mutations in the human ATP-binding cassette transporters ABCG5 and ABCG8 in sitosterolemia. Hum. Mutat. 20: 151.
26. Lam, C-W., A. W-F. Cheng, S-F. Ton, and Y-W. Chan. 2002. Novel donor splice site mutation of ABCG5 gene in sitosterolemia. Mol. Genet. Metab. 75: 178-180.
27. Mymin, D., J. Wang, J. Frohlich, and R. A. Hegele. 2003. Image in cardiovascular medicine. Aortic xanthomatosis with coronary ostial occlusion in a child homozygous for a nonsense mutation in ABCG8. Circulation. 107: 791.
28. Moghadasian, M. H., and J. J. Frohlich. 1999. Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis: clinical and experimental evidence. Am. J. Med. 107: 588-594.
29. Lee, M-H., K. Lu, and S. B. Patel. 2001. Genetic basis of sitosterolemia. Curr. Opin. Lipidol. 12: 141-149.
30. Iida, A., S. Saito, A. Sekine, C. Mishima, Y. Kitamura, K. Kondo, S. Harigae, S. Osawa, and Y. Nakamura. 2002. Catalog of 605 single-nucleotide polymorphisms (SNPs) among 13 genes encoding human ATP-binding cassette transporters: ABCA4, ABCA7, ABCA8, ABCD1, ABCD3, ABCD4, ABCE1, ABCF1, ABCG1, ABCG2, ABCG4, ABCG5, and ABCG8. J. Hum. Genet. 47: 285-310.
31. Sniderman, A., S. Shapiro, D. Marpole, B. Skinner, B. Teng, and P. O. Kwiterovich, Jr. 1980. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (β) lipoproteins]. Proc. Natl. Acad. Sci. USA. 77: 604-608.
32. Mills, G. L., C. E. Taylaur, and M. J. Chapman. 1976. Low-density lipoproteins in patients homozygous for familial hyperbetalipoproteinemia. Clin. Sci. Mol. Med. 51: 221-231.
33. Nguyen, L., S. Shefer, G. Salen, I. Horak, G. S. Tint, and D. J. McNamara. 1988. The effect of abnormal plasma and cellular sterol content and composition on low density lipoprotein uptake and degradation by monocytes and lymphocytes in sitosterolemia with xanthomatosis. Metabolism. 37: 346-351.
34. Nguyen, L., G. Shefer, G. Salen, G. S. Tint, and A. K. Batta. 1998. Competitive inhibition of hepatic sterol 27-hydroxylase by sitosterol: decreased activity in sitosterolemia. Proc. Assoc. Am. Phys. 10: 32-39.
35. Shefer, S., G. Salen, L. Nguyen, A. K. Batta, V. Packin, G. S. Tint, and S. Hauser. 1988. Competitive inhibition of bile acid synthesis by endogenous cholestanol and sitosterol in sitosterolemia with xanthomatosis-effect on cholesterol 7α-hydroxylase. J. Clin. Invest. 82: 1833-1839.
36. Parsons, H. G., R. Jamal, and B. Baylis. 1995. A marked and sustained reduction in LDL sterols by diet and cholestyramine in β-sitosterolemia. Clin. Invest. Med. 18: 389-400.
37. Belamarich, P. F., R. J. Deckelbaum, T. J. Starc, B. E. Dobrin, G. S. Tint, and G. Salen. 1990. Response to diet and cholestyramine in a patient with sitosterolemia. Pediatrics. 86: 977-981.
38. Salen, G., K. von Bergmann, D. Lutjohann, P. Kwiterovich, J. Kane, S. B. Patel, T. Musliner, P. Stein, and B. Musser. 2004. Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation. 109: 966-971.
39. Remaley, A. T., S. Bark, A. D. Walts, L. Freeman, S. Shulenin, T. Annilo, E. Elgin, H. E. Rhodes, C. Joyce, M. Dean, S. Santamarina-Fojo, and H. B. Brewer, Jr. 2002. Comparative genome analysis of potential regulatory elements in the ABCG5-ABCG8 gene cluster. Biochem. Biophys. Res. Commun. 295: 276-282.
40. Repa, J. J., K. E. Berge, C. Pomajzl, J. A. Richardson, H. Hobbs, and D. J. Mangelsdorf. 2002. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors α and β. J Biol. Chem. 277: 18793-18800.
41. Graf, G. A., W-P. Li, R. D. Gerard, I. Gelissen, A. White, J. C. Cohen, and H. H. Hobbs. 2002. Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J. Clin. Invest. 110: 659-669.
42. Yu, L., J. Li-Hawkins, R. E. Hammer, K. E. Berge, J. D. Horton, J. C. Cohen, and H. H. Hobbs. 2002. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J. Clin. Invest. 110: 671-680.
43. Yu, L., R. E. Hammer, J. Li-Hawkins, K. van Bergmann, D. Lutjohann, J. C. Cohen, and H. H. Hobbs. 2002. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc. Natl. Acad. Sci. USA. 99: 16237-16242.